MENU
+Compare
CRNX
Stock ticker: NASDAQ
AS OF
Apr 28, 11:16 AM (EDT)
Price
$33.11
Change
+$0.72 (+2.22%)
Capitalization
3.03B

CRNX Crinetics Pharmaceuticals Forecast, Technical & Fundamental Analysis

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CRNX with price predictions
Apr 22, 2025

CRNX's Stochastic Oscillator is sitting in overbought zone for 3 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CRNX entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRNX's RSI Indicator exited the oversold zone, of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on CRNX as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRNX just turned positive on April 15, 2025. Looking at past instances where CRNX's MACD turned positive, the stock continued to rise in of 53 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRNX advanced for three days, in of 282 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRNX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CRNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.289) is normal, around the industry mean (13.917). P/E Ratio (0.000) is within average values for comparable stocks, (62.940). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.781). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. CRNX's P/S Ratio (2500.000) is very high in comparison to the industry average of (251.270).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CRNX is expected to report earnings to rise 5.37% to -92 cents per share on May 08

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q1'25
Est.
$-0.93
Q4'24
Est.
$-0.88
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.08
Q1'24
Missed
by $0.13
The last earnings report on February 27 showed earnings per share of -87 cents, meeting the estimate of -87 cents. With 46.43K shares outstanding, the current market capitalization sits at 3.03B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA284.9525.44
+9.80%
Tesla
GME27.460.38
+1.40%
GameStop Corp
SPY550.643.95
+0.72%
SPDR® S&P 500® ETF
AAPL209.280.91
+0.44%
Apple
BTC.X93754.840000-892.085940
-0.94%
Bitcoin cryptocurrency

CRNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with TRDA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
-2.99%
TRDA - CRNX
53%
Loosely correlated
-1.34%
DNLI - CRNX
52%
Loosely correlated
+1.23%
RVMD - CRNX
52%
Loosely correlated
+0.49%
XNCR - CRNX
51%
Loosely correlated
-3.04%
ARWR - CRNX
51%
Loosely correlated
-0.67%
More